|
Oct 8, 2025 |
Hill Christopher James
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 2, 2025 |
Sep 3, 2025 |
Wood Gavin
|
CFO |
Sell |
27.5
|
-96,000
|
-100.00%
|
✗
|
$950.4 |
| Aug 28, 2025 |
Aug 29, 2025 |
Bertrand William C JR
|
COO |
Sell |
27.5
|
-207,000
|
-17.35%
|
✗
|
$2.1K |
| Aug 15, 2025 |
Aug 19, 2025 |
Behbahani Ali
|
Director |
Sell |
22.5
|
-19,500,000
|
-100.00%
|
✗
|
$229.2K |
| Jul 28, 2025 |
Jul 30, 2025 |
EcoR1 Capital, LLC
|
10% Owner |
Sell |
16.3
|
-64,052,538
|
-38.96%
|
✗
|
$6.9M |
| Feb 20, 2025 |
Feb 20, 2025 |
Bertrand William C JR
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2025 |
Feb 20, 2025 |
Brewer Joanna Elizabeth
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2025 |
Feb 20, 2025 |
Lunger John
|
Chief Patient Supply Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2025 |
Feb 20, 2025 |
Piccina Cintia
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2025 |
Feb 20, 2025 |
Norry Elliot
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2025 |
Feb 20, 2025 |
Rawcliffe Adrian
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 17, 2025 |
Jan 17, 2025 |
Norry Elliot
|
Chief Medical Officer |
Sell |
47.5
|
-5,584
|
-42.65%
|
✗
|
$3.2K |
| Jan 17, 2025 |
Jan 17, 2025 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
47.5
|
-5,584
|
-42.65%
|
✗
|
$3.2K |
| Jan 17, 2025 |
Jan 17, 2025 |
Bertrand William C JR
|
COO |
Sell |
47.5
|
-5,584
|
-42.65%
|
✗
|
$3.2K |
| Jan 17, 2025 |
Jan 17, 2025 |
Rawcliffe Adrian
|
CEO |
Sell |
46.3
|
-30,601
|
-40.84%
|
✗
|
$17.8K |
| Jan 13, 2025 |
Jan 15, 2025 |
Rawcliffe Adrian
|
CEO |
Sell |
46.3
|
-59,569
|
-41.18%
|
✗
|
$34.6K |
| Jan 15, 2025 |
Jan 15, 2025 |
Piccina Cintia
|
Chief Commercial Officer |
Sell |
47.5
|
-12,991
|
-41.36%
|
✗
|
$7.5K |
| Jan 13, 2025 |
Jan 15, 2025 |
Norry Elliot
|
Chief Medical Officer |
Sell |
46.3
|
-22,195
|
-41.63%
|
✗
|
$12.9K |
| Jan 13, 2025 |
Jan 15, 2025 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
46.3
|
-19,542
|
-41.79%
|
✗
|
$11.4K |
| Jan 13, 2025 |
Jan 15, 2025 |
Bertrand William C JR
|
COO |
Sell |
46.3
|
-19,542
|
-41.79%
|
✗
|
$11.4K |
| Jul 1, 2024 |
Jul 1, 2024 |
Behbahani Ali
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2024 |
Jul 1, 2024 |
MOTT DAVID M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2024 |
Jul 1, 2024 |
Menzel Garry E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2024 |
Jul 1, 2024 |
Hege Kristen
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2024 |
Jul 1, 2024 |
Hegde Priti
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2024 |
Jul 1, 2024 |
Furey John
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2024 |
Jul 1, 2024 |
Alleva Lawrence M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2024 |
Jul 1, 2024 |
Allen Andrew R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 18, 2024 |
Piccina Cintia
|
Chief Commercial Officer |
Sell |
46.3
|
-24,531
|
-39.05%
|
✗
|
$22.8K |
|
Mar 26, 2024 |
EcoR1 Capital, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 18, 2024 |
Mar 18, 2024 |
Piccina Cintia
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2024 |
Jan 17, 2024 |
Rawcliffe Adrian
|
CEO |
Sell |
46.3
|
-39,384
|
-40.05%
|
✗
|
$27.6K |
| Jan 16, 2024 |
Jan 17, 2024 |
Norry Elliot
|
Chief Medical Officer |
Sell |
46.3
|
-20,563
|
-40.34%
|
✗
|
$14.1K |
| Jan 16, 2024 |
Jan 17, 2024 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
46.3
|
-22,795
|
-40.26%
|
✗
|
$15.9K |
| Jan 16, 2024 |
Jan 17, 2024 |
Bertrand William C JR
|
COO |
Sell |
46.3
|
-23,589
|
-40.26%
|
✗
|
$16.4K |
| Jan 15, 2024 |
Jan 17, 2024 |
Behbahani Ali
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2024 |
Jan 17, 2024 |
Bertrand William C JR
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2024 |
Jan 17, 2024 |
Hege Kristen
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2024 |
Jan 17, 2024 |
Lunger John
|
Chief Patient Supply Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2024 |
Jan 17, 2024 |
Brewer Joanna Elizabeth
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2024 |
Jan 17, 2024 |
TAYTON-MARTIN HELEN KATRINA
|
Chief Business & Strgy Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2024 |
Jan 17, 2024 |
Wood Gavin
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2024 |
Jan 17, 2024 |
Norry Elliot
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2024 |
Jan 17, 2024 |
Rawcliffe Adrian
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 11, 2024 |
Jan 12, 2024 |
Norry Elliot
|
Chief Medical Officer |
Sell |
46.3
|
-11,808
|
-39.69%
|
✗
|
$10K |
| Jan 11, 2024 |
Jan 12, 2024 |
Bertrand William C JR
|
COO |
Sell |
47.5
|
-9,229
|
-39.77%
|
✗
|
$7.8K |
| Jan 11, 2024 |
Jan 12, 2024 |
Rawcliffe Adrian
|
CEO |
Sell |
46.3
|
-29,202
|
-39.47%
|
✗
|
$24.7K |
| Jan 11, 2024 |
Jan 12, 2024 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
47.5
|
-9,229
|
-39.77%
|
✗
|
$7.8K |
|
Nov 1, 2023 |
Hege Kristen
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 1, 2023 |
Sep 1, 2023 |
Rawcliffe Adrian
|
CEO |
Sell |
47.5
|
-2,403
|
-41.06%
|
✗
|
$1.9K |
| Aug 1, 2023 |
Aug 1, 2023 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
47.5
|
-3,096
|
-39.62%
|
✗
|
$2.8K |
| Jul 10, 2023 |
Jul 10, 2023 |
Menzel Garry E
|
Director |
Sell |
46.3
|
-47,702
|
-38.86%
|
✗
|
$43.4K |
| Jul 5, 2023 |
Jul 5, 2023 |
Hegde Priti
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 5, 2023 |
Jul 5, 2023 |
Allen Andrew R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 5, 2023 |
Jul 5, 2023 |
Menzel Garry E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2023 |
Jul 3, 2023 |
Behbahani Ali
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2023 |
Jul 3, 2023 |
Hegde Priti
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2023 |
Jul 3, 2023 |
Furey John
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2023 |
Jul 3, 2023 |
Menzel Garry E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2023 |
Jul 3, 2023 |
Sigal Charles Elliott
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2023 |
Jul 3, 2023 |
Alleva Lawrence M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2023 |
Jul 3, 2023 |
MOTT DAVID M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2023 |
Jul 3, 2023 |
Allen Andrew R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 27, 2023 |
Jun 27, 2023 |
Rawcliffe Adrian
|
CEO |
Sell |
47.5
|
-2,333
|
-39.87%
|
✗
|
$2.1K |
| Jun 1, 2023 |
Jun 1, 2023 |
Menzel Garry E
|
Director |
Neutral |
90.0
|
+611,224
|
100.00%
|
✗
|
- |
|
Jun 1, 2023 |
Menzel Garry E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 1, 2023 |
Hegde Priti
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 1, 2023 |
Allen Andrew R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 31, 2023 |
Jan 31, 2023 |
Piccina Cintia
|
Chief Commercial Officer |
Sell |
46.3
|
-11,890
|
-37.84%
|
✗
|
$22.2K |
| Jan 17, 2023 |
Jan 17, 2023 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
47.5
|
-4,440
|
-37.94%
|
✗
|
$8.2K |
| Jan 17, 2023 |
Jan 17, 2023 |
Bertrand William C JR
|
COO |
Sell |
47.5
|
-4,440
|
-37.94%
|
✗
|
$8.2K |
| Jan 17, 2023 |
Jan 17, 2023 |
Norry Elliot
|
Chief Medical Officer |
Sell |
47.5
|
-2,159
|
-38.21%
|
✗
|
$4K |
| Jan 17, 2023 |
Jan 17, 2023 |
Rawcliffe Adrian
|
CEO |
Sell |
46.3
|
-10,057
|
-42.96%
|
✗
|
$18.7K |
| Jan 17, 2023 |
Jan 17, 2023 |
Bertrand William C JR
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 17, 2023 |
Jan 17, 2023 |
Lunger John
|
Chief Patient Supply Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 17, 2023 |
Jan 17, 2023 |
Brewer Joanna Elizabeth
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 17, 2023 |
Jan 17, 2023 |
TAYTON-MARTIN HELEN KATRINA
|
Chief Business & Strgy Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 17, 2023 |
Jan 17, 2023 |
Wood Gavin
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 17, 2023 |
Jan 17, 2023 |
Norry Elliot
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 17, 2023 |
Jan 17, 2023 |
Piccina Cintia
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 17, 2023 |
Jan 17, 2023 |
Rawcliffe Adrian
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 11, 2023 |
Jan 12, 2023 |
Bertrand William C JR
|
COO |
Sell |
46.3
|
-8,816
|
-37.99%
|
✗
|
$15.2K |
| Jan 11, 2023 |
Jan 12, 2023 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
46.3
|
-8,816
|
-37.99%
|
✗
|
$15.2K |
| Jan 11, 2023 |
Jan 12, 2023 |
Norry Elliot
|
Chief Medical Officer |
Sell |
46.3
|
-11,292
|
-37.95%
|
✗
|
$19.4K |
| Jan 11, 2023 |
Jan 12, 2023 |
Rawcliffe Adrian
|
CEO |
Sell |
42.5
|
-31,805
|
-42.99%
|
✗
|
$54.8K |
| Jan 4, 2023 |
Jan 4, 2023 |
Bertrand William C JR
|
COO |
Sell |
47.5
|
-3,584
|
-38.27%
|
✗
|
$6.1K |
| Jan 4, 2023 |
Jan 4, 2023 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,100
|
-38.94%
|
✗
|
$1.9K |
| Jan 4, 2023 |
Jan 4, 2023 |
Norry Elliot
|
Chief Medical Officer |
Sell |
47.5
|
-876
|
-39.16%
|
✗
|
$1.5K |
| Jan 4, 2023 |
Jan 4, 2023 |
Rawcliffe Adrian
|
CEO |
Sell |
47.5
|
-5,073
|
-43.34%
|
✗
|
$8.6K |
| Sep 1, 2022 |
Sep 1, 2022 |
Rawcliffe Adrian
|
CEO |
Sell |
47.5
|
-2,536
|
-43.34%
|
✗
|
$5K |
| Aug 1, 2022 |
Aug 1, 2022 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
47.5
|
-2,983
|
-38.18%
|
✗
|
$5.3K |
| Aug 1, 2022 |
Aug 1, 2022 |
Piccina Cintia
|
Chief Commercial Officer |
Sell |
46.3
|
-21,040
|
-37.66%
|
✗
|
$37.3K |
| Jul 5, 2022 |
Jul 5, 2022 |
Lunger John
|
Chief Patient Supply Officer |
Sell |
47.5
|
-1,973
|
-38.86%
|
✗
|
$3.3K |
| Jul 1, 2022 |
Jul 1, 2022 |
Behbahani Ali
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2022 |
Jul 1, 2022 |
Zaks Tal Zvi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2022 |
Jul 1, 2022 |
Alleva Lawrence M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2022 |
Jul 1, 2022 |
Furey John
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2022 |
Jul 1, 2022 |
Noble James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2022 |
Jul 1, 2022 |
Sigal Charles Elliott
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2022 |
Jul 1, 2022 |
Duncan Barbara Gayle
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |